Natural course of inoperable esophageal cancer treated with metallic expandable stents: Quality of life and cost-effectiveness analysis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 19, Issue 12, 2004, Pages 1397-1402

  Xinopoulos, Dimitrios ^a   Dimitroulopoulos, Dimitrios ^a,d   Moschandrea, Ioanna ^b   Skordilis, Panagiotis ^b   Bazinis, Athanassios ^a   Kontis, Marios ^a   Paraskevas, Ioannis ^c   Kouroumalis, Elias ^b   Paraskevas, Emmanuel ^a  

^a SAINT SAVVAS HOSPITAL   (Greece)

^b UNIVERSITY HOSPITAL OF IRAKLION   (Greece)

^c CITY UNIVERSITY   (United Kingdom)

^d Economics and Statistics Department 'Saint Savvas' Cancer Hospital ^*  (Greece)

Author keywords

Cost effectiveness; Esophageal cancer; Metal stents; Palliation; Quality of life; Survival

Indexed keywords

METAL;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER SURVIVAL; COST EFFECTIVENESS ANALYSIS; DYSPHAGIA; ENDOSCOPIC THERAPY; ESOPHAGOBRONCHIAL FISTULA; ESOPHAGUS CANCER; ESOPHAGUS OBSTRUCTION; ESOPHAGUS PROSTHESIS; ESOPHAGUS STENOSIS; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LASER SURGERY; LOWER ESOPHAGUS SPHINCTER; MALE; MEDICAL INSTRUMENTATION; MONEY; PALLIATIVE THERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; SAFETY; SAVARY DILATOR; SQUAMOUS CELL CARCINOMA; STENT; SURVIVAL TIME;

EID: 11144239657     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2004.03507.x     Document Type: Article

References (41)

1. Rankin S, Mason R. Staging of esophageal carcinoma. Clin. Radiol. 1992; 46: 373-7.
2. Earlam R, Cunha-Melo JR. Esophageal squamous cell carcinoma: a critical review of surgery. Br. J. Surg. 1980; 67: 381-5.
3. Knyrim K, Wagner HJ, Bethge N et al. A controlled trial of an expendable metal stent for palliation of esophageal obstruction due to inoperable cancer. N. Engl. J. Med. 1993; 329: 1302-7.
4. Ahmed ME, Gustavsson S. Current palliative modalities for esophagal carcinoma. Acta Chir. Scand. 1990; 156: 95-8.
5. Bremmer RM, De Meester TR. Surgical treatment of esophageal carcinoma. Gastroenterol. Clin. North Am. 1991; 20: 743-63.
6. Muller JM, Erasmi H, Stelzner M et al. Surgical therapy of esophageal carcinoma. Br. J. Surg. 1990; 77: 845-57.
7. Tytgat GN. Endoscopic review of esophageal cancer: possibilities and limitations. Endoscopy 1990; 22: 263-7.
8. Nash CL, Gerder H. Methods of palliation of esophageal and gastric cancer. Surg. Oncol. Clin. N. Am. 2002; 11: 459-83.
9. Kubba AK, Krasmer N. An update in the palliative management of malignant dysphagia. Eur. J. Surg. Oncol. 2001; 26: 116-29.
10. Maier A, Anegg U, Lunzer R et al. The effect of external beam irradiation after endoscopic palliation of esophageal carcinoma. Oncol. Rep. 2000; 7: 375-9.
11. Moses FM, Peura DA, Wong RKH et al. Palliative dilation of esophageal carcinoma. Gastrointest. Endosc. 1985; 31: 61-3.
12. Dallal HJ, Smith GD, Grieve DC et al. A randomized trial of thermal ablative therapy versus expandable metal stents in the palliative treatment of patients with esophageal carcinoma. Gastrointest. Endosc. 2001; 54: 549-57.
13. Harbord M, Dawes RF, Barr H et al. Palliation of patients with dysphagia due to advanced esophageal cancer by endoscopic injection of cisplatin/epinephrine injectable gel. Gastrointest. Endosc. 2002; 56: 644-51.
14. Lukeetich JD, Christine NA, Buenaventura PO et al. Endoscopic photodynamic therapy for obstructing esophageal cancer: 77 cases over a 2 year period. Surg. Endosc. 2000; 14: 653-7.
15. Sur RK, Levin CV, Dande B et al. Prospective randomized trial of HDR brahytherapy as a sole modality in palliation of advanced esophageal carcinoma - an International Atomic Energy Agency study. Int. J. Radiat. Oncol. Biol. Phys. 2003; 5: 218-19.
16. Monga A, Kumar D, Jain SK. Laser palliation of esophageal carcinoma. J. Assoc. Physicians India 2002; 50: 1017-21.
17. Leiper K, Morris AI. Treatment of oesophago-gastric tumours. Endoscopy 2002; 34: 139-45.
18. Loizou LA, Grigg D, Atkinson M et al. A prospective comparison of laser therapy and intubation in endoscopic palliation for malignant dysphagia. Gastroenterology 1991; 100: 1303-10.
19. Pasricha PJ, Fleischer DE, Kalloo AN. Endoscopic perforations of the upper digestive tract: a review of their pathogenesis, prevention and management. Gastroenterology 1994; 106: 787-802.
20. Fugger R, Niederle B, Jantsch H et al. Endoscopic tube implantation for the palliation of malignant esophageal stenosis. Endoscopy 1990; 22: 101-4.
21. Vakil N, Morris AI, Marcon N et al. A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction. Am. J. Gastroenterol. 2001; 96: 1791-6.
22. Siersema PD, Hop WCJ, van Blankstein M et al. A comparison of three types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest. Endosc. 2001; 54: 145-53.
23. Mellow MH, Pinkas H. Endoscopic laser therapy for malignancies affecting the esophagus and gastroesophageal junction. analysis of technical and functional efficacy. Arch. Intern. Med. 1985; 145: 1443-6.
24. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 1959; 53: 457-81.
25. Aaronson NK, Ahmedzai S, Bergman B et al. The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J. Natl Cancer Inst. 1993; 85: 365-76.
26. Lambert R. An overview of the management of cancer of the esophagus. Gastrointest. Endosc. Clin. N. Am. 1998; 8: 415-34.
27. Domschke W, Foerster ECh, Matek W et al. Self-expanding mesh stent for esophageal cancer stenosis. Endoscopy 1990; 22: 134-6.
28. Lambert R. Treatment of esophagogastric tumors. Endoscopy 2003; 35: 118-26.
29. McManus K, Khan I, McGuigan J. Self-expanding esophageal stents: strategies for re-intervention. Endoscopy 2001; 33: 601-4.
30. Singhvi R, Abbasakoor F, Manson JM. Insertion of self-expanding metal stents for malignant dysphagia: assessment of a simple endoscopic method. Ann. R. Coll. Surg. Engl. 2000; 82: 243-8.
31. Takkanen VJ, Nemlander AT, Ramo OJ et al. Expandable metallic stents in the management of malignant esophageal obstruction. Ann. Chir. Gynaecol. 2000; 89: 20-3.
32. Siersema PD, Marcon N, Vakil N. Metal stents for tumors of the distal esophagus and the gastric cardia. Endoscopy 2003; 35: 79-85.
33. Lee SH. The role of esophageal stenting in the nonsurgical management of esophageal strictures. Br. J. Radiol. 2001; 74: 891-900.
34. Nicholson DA, Haycox A, Kay CL et al. The cost effectiveness of metal esophageal stenting in malignant disease compared with conventional therapy. Clin. Radiol. 1999; 54: 212-15.
35. Cowling MG, Mason RC, Adam AN. Esophageal and upper GI stenting. Radiology 1999; 2: 2-7.
36. Warren WH. Palliation of dysphagia. Chest Surg. Clin. N. Am. 2000; 10: 605-23.
37. Laasch HU, Marriott A, Wilbraham L et al. Effectiveness of open versus antireflux stents for palliation of distal esophageal carcinoma and prevention of symptomatic gastroesophageal reflux. Radiology 2002; 225: 359-65.
38. Watkinson AF, Ellul J, Entwisle K et al. Esophageal carcinoma: initial results of palliative treatment with covered self-expanding endoprostheses. Radiology 1995; 195: 821-7.
39. Sabharwal T, Hamady MS, Chui S et al. A randomised prospective comparison of the flamingo wall-stent and ultraflex stent for palliation of dysphagia associated with lower third esophageal carcinoma. Gut 2003; 52: 922-6.
40. Rozanes I, Poyanli A, Acunas B. Palliative treatment of inoperable malignant esophageal strictures with metal stents: one center's experience with four different stents. Eur. J. Radiol. 2002; 43: 196-203.
41. Mc Grath JP, Browne M, Riordan C et al. Expandable metal stents in the palliation of malignant dysphagia and esophageal-respiratory fistulae. Ir. Med. J. 2001; 94: 270-2.